Cargando…
TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo
Engineering T-cells to express receptors specific for antigens present on tumour tissue is proving a highly effective treatment for some leukaemias. However, extending this to solid tumours requires antigens that can be safely and effectively targeted. TEM8, a marker overexpressed on the vasculature...
Autores principales: | Petrovic, Kristina, Robinson, Joseph, Whitworth, Katharine, Jinks, Elizabeth, Shaaban, Abeer, Lee, Steven P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797195/ https://www.ncbi.nlm.nih.gov/pubmed/31622431 http://dx.doi.org/10.1371/journal.pone.0224015 |
Ejemplares similares
-
Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics
por: Corbett, Virginia, et al.
Publicado: (2022) -
Broad Expression Analysis of Human ANTXR1/TEM8 Transcripts Reveals Differential Expression and Novel Splizce Variants
por: Vargas, Micaela, et al.
Publicado: (2012) -
Correction: Broad Expression Analysis of Human ANTXR1/TEM8 Transcripts Reveals Differential Expression and Novel Splizce Variants
por: Vargas, Micaela, et al.
Publicado: (2012) -
An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours
por: Robinson, Joseph, et al.
Publicado: (2020) -
Targeting the tumor vasculature with TEM8-specific T cells
por: Williams, LaTerrica C, et al.
Publicado: (2014)